Grant: Doctoral: Vanier Canada Graduate Scholarships
University of British Columbia
$150,000.00
Discovery and characterization of novel monogenic causes of allergic diseases in humans
EF 2020-21
Résumé
The immune system plays critical roles in protecting us against a wide range of diseases. However, the dysregulation of the immune system not only makes us more susceptible to infections, but it can also lead to the development of allergic diseases. My research aims to identify and understand the genetic changes which cause the immune system to become dysregulated and result in severe and rare allergic diseases in humans. By collaborating with clinicians across Western Canada, I will be recruiting individuals with severe and early onset allergic disorders into our study and sequencing their DNA to look for genetic changes (mutations) that could explain their allergic symptoms. By using cells directly isolated from these patients, I will assess the impact of these mutations on the functioning of their immune system. I will also look for and test existing treatments which can restore proper immune system functioning and alleviate their allergic symptoms. Lastly, I will determine if milder forms of these genetic changes are associated with less-severe, more common allergic diseases in the greater population. Understanding the genetic causes of these severe and rare allergic diseases will not only be life changing for the affected individuals and their families, but it also has the potential to help other similarly affected individuals worldwide. Additionally, with a better understanding of how these allergic diseases are caused, we can develop new treatments that can precisely target the affected parts of the immune system, resulting in significantly better outcomes for the patients.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
437236
Name
Vaseghi-Shanjani Maryam
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Discovery and characterization of novel monogenic causes of allergic diseases in humans
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunoblotting; Inborn Errors Of Immunity; Monogenic Allergic Diseases; Quantitative Polymerase Chain Reaction; Reporter Assays; Transcriptome Analysis; Whole-Genome Association Analysis; Whole-Genome Sequencing
Abstract
The immune system plays critical roles in protecting us against a wide range of diseases. However, the dysregulation of the immune system not only makes us more susceptible to infections, but it can also lead to the development of allergic diseases. My research aims to identify and understand the genetic changes which cause the immune system to become dysregulated and result in severe and rare allergic diseases in humans. By collaborating with clinicians across Western Canada, I will be recruiting individuals with severe and early onset allergic disorders into our study and sequencing their DNA to look for genetic changes (mutations) that could explain their allergic symptoms. By using cells directly isolated from these patients, I will assess the impact of these mutations on the functioning of their immune system. I will also look for and test existing treatments which can restore proper immune system functioning and alleviate their allergic symptoms. Lastly, I will determine if milder forms of these genetic changes are associated with less-severe, more common allergic diseases in the greater population. Understanding the genetic causes of these severe and rare allergic diseases will not only be life changing for the affected individuals and their families, but it also has the potential to help other similarly affected individuals worldwide. Additionally, with a better understanding of how these allergic diseases are caused, we can develop new treatments that can precisely target the affected parts of the immune system, resulting in significantly better outcomes for the patients.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Vaseghi-Shanjani, Maryam
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~